Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins

Neuron

Volumn 19, Issue 4, 1997, Pages 939-945

  Borchelt, David R ^a   Ratovitski, Tamara ^a   Van Lare, Judy ^a   Lee, Michael K ^a   Gonzales, Vicki ^a   Jenkins, Nancy A ^b   Copeland, Neal G ^b   Price, Donald L ^a   Sisodia, Sangram S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; PRESENILIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DEGENERATIVE DISEASE; GENE MUTATION; IMMUNOCYTOCHEMISTRY; MISSENSE MUTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

EID: 0030833055     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6273(00)80974-5     Document Type: Article

References (51)

1. Alzheimer's Disease Collaborative Group (1995). The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families. Nature Genet. 11, 219-222.
2. Barelli, H., Lebeau, A., Vizzavona, J., Delaere, P., Chevallier, N., Drouot, C., Marambaud, P., Ancolio, K., Buxbaum, J.D., Khorkova, O., et al. (1997). Characterization of new polyclonal antibodies specific for 40 and 42 amino acid-long amyloid β peptides: their use to examine the cell biology of presenilins and the immunohistochemistry of sporadic Alzheimer's disease and cerebral amyloid angiopathy cases. Mol. Med., in press.
3. Borchelt, D.R., Koliatsos, V.E., Guarnieri, M., Pardo, C.A., Sisodia, S.S., and Price, D.L. (1994). Rapid anterograde axonal transport of the cellular prion glycoprotein in the peripheral and central nervous systems. J. Biol. Chem. 269, 14711-14714.
4. Borchelt, D.R., Davis, J., Fischer, M., Lee, M.K., Slunt, H.H., Ratovitsky, T., Regard, J., Copeland, N.G., Jenkins, N.A., Sisodia, S.S., and Price, D.L. (1996a). A vector for expressing foreign genes in the brains and hearts of transgenic mice. Genet. Anal. [Biomed. Eng.] 13, 159-163.
5. Borchelt, D.R., Thinakaran, G., Eckman, C.B., Lee, M.K., Davenport, F., Ratovitsky, T., Prada, C.-M., Kim, G., Seekins, S., Yager, D., et al. (1996b). Familial Alzheimer's disease-linked presenilin 1 variants elevate Aβ1-42/1-40 ratio in vitro and in vivo. Neuron 17, 1005-1013.
6. Boteva, K., Vitek, M., Mitsuda, H., de Silva, H., Xu, P.-T., Small, G., and Gilbert, J.R. (1996). Mutation analysis of presenilin 1 gene in Alzheimer's disease. Lancet 347, 130-131.
7. Cai, X.-D., Golde, T.E., and Younkin, S.G. (1993). Release of excess amyloid β protein from a mutant amyloid β protein precursor. Science 259, 514-516.
8. Campion, D., Brice, A., Dumanchin, C., Puel, M., Baulac, M., De la Sayette, V., Hannequin, D., Duyckaerts, C., Michon, A., Martin, C., et al. (1996). A novel presenilin 1 mutation resulting in familial Alzheimer's disease with an onset age of 29 years. Neuroreport 7, 1582-1584.
9. Chapman, J., Asherov, A., Wang, N., Treves, T.A., Korczyn, A.D., and Goldfarb, L.G. (1995). Familial Alzheimer's disease associated with S182 codon 286 mutation. Lancet 346, 1040.
10. Chartier-Harlin, M.-C., Crawford, F., Houlden, H., Warren, A., Hughes, D., Fidani, L., Goate, A., Rossor, M., Roques, P., Hardy, J., and Mullan, M. (1991). Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene. Nature 353, 844-846.
11. Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A.Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., and Selkoe, D.J. (1992). Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production. Nature 360, 672-674.
12. Citron, M., Westaway, D., Xia, W., Carlson, G., Diehl, T., Levesque, G., Johnson-Wood, K., Lee, M., Seubert, P., Davis, A., et al. (1997). Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice. Nature Med. 3, 67-72.
13. Cruts, M., Backhovens, H., Wang, S.Y., Vangassen, G., Theuns, J., Dejonghe, C., Wehnert, A., Devoecht, J., deWinter, G., Cras, P., et al. (1995). Molecular genetic analysis of familial early-onset Alzheimer's disease linked to chromosome 14Q24.3. Hum. Mol. Genet. 4, 2363-2371.
14. Duff, K., Eckman, C., Zehr, C., Yu, X., Prada, C.-M., Perez-Tur, J., Hutton, M., Buee, L., Harigaya, Y., Yager, D., et al. (1996). Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1. Nature 383, 710-713.
15. Games, D., Adams, D., Alessandrini, R., Barbour, R., Berthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995). Alzheimer-type neuropathology in transgenic mice over-expressing V717F β-amyloid precursor protein. Nature 373, 523-527.
16. Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991). Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349,704-706.
17. Gravina, S.A., Ho, L., Eckman, C.B., Long, K.E., Otvos, L., Jr., Younkin, L.H., Suzuki, N., and Younkin, S.G. (1995). Amyloid β protein (Aβ) in Alzheimer's disease brain. J. Biol. Chem. 270, 7013-7016.
18. Haass, C., Schlossmacher, M.G., Hung, A.Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B.L., Lieberburg, I., Koo, E.H., Schenk, D., Teplow, D.B., and Selkoe, D.J. (1992). Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature 359, 322-325.
19. Haass, C., Hung, A.Y., Selkoe, D.J., and Teplow, D.B. (1994). Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid β-protein precursor. J. Biol. Chem. 269, 17741-17748.
20. Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., and Cole, G. (1996). Correlative memory deficits, Aβ elevation and amyloid plaques in transgenic mice. Science 274, 99-102.
21. Iwatsubo, T., Odaka, A., Suzuki, N., Mizusawa, H., Nukina, N., and Ihara, Y. (1994). Visualization of Aβ42(43)-positive and Aβ40-positive senile plaques with end-specific Aβ-monoclonal antibodies: evidence that an initially deposited Aβ species is Aβ1-42(43). Neuron 13, 45-53.
22. Iwatsubo, T., Mann, D.M.A., Odaka, A., Suzuki, N., and Ihara, Y. (1995). Amyloid β protein (Aβ) deposition: Aβ42(43) preceds Aβ40 in Down syndrome. Ann. Neurol. 37, 294-299.
23. Iwatsubo, T., Saido, T.C., Mann, D.M.A., Lee, V.M.Y., and Trojanowski, J.Q. (1996). Full-length amyloid-β(1-42(43)) and amino-terminally modified and truncated amyloid-42(43) deposit in diffuse plaques. Am. J. Pathol. 149, 1823-1830.
24. Jarrett, J.T., Berger, E.P., and Lansbury, P.T., Jr. (1993).The carboxy terminus of the amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 32, 4693-4697.
25. Kim, K.S., Wen, G.Y., Bancher, C., Chen, C.M.J., Sapienza, V.J., Hong, H., and Wisniewski, H.M. (1990). Detection and quantitation of amyloid β-peptide with 2 monoclonal antibodies. Neurosci. Res. Commun. 7, 113-122.
26. Lee, M.K., Borchelt, D.R., Kim, G., Thinakaran, G., Slunt, H.H., Ratovitski, T., Martin, L.J., Kittur, A., Gandy, S., Levey, A.I., et al. (1997). Hyperaccumulation of FAD-linked presenilin 1 variants in vivo. Nature Med. 3, 756-760.
27. Lemere, C.A., Blusztajn, J.K., Yamaguchi, H., Wisniewski, T., Saido, T.C., and Selkoe, D.J. (1996). Sequence of deposition of heterogeneous amyloid β-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation. Neurobiol. Dis. 3, 16-32.
28. Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D.M., Oshima, J., Pettingell, W.H., Yu, C.-E., Jondro, P.D., Schmidt, S.D., Wang, K., et al. (1995). Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269, 973-977.
29. 42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene. Am. J. Pathol. 148, 1257-1266.
30. Martin, L.J., Pardo, C.A., Cork, L.C., and Price, D.L. (1994). Synaptic pathology and glial responses to neuronal injury precede the formation of senile plaques and amyloid deposits in the aging cerebral cortex. Am. J. Pathol. 145, 1358-1381.
31. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., and Stadlan, E.M. (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944.
32. Mullan, M., Crawford, F., Axelman, K., Houlden, H., Lillius, L., Winblad, B., and Lannfelt, L. (1992). A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of β-amyloid. Nature Genet. 1, 345-347.
33. Nakano, I., and Hirano, A. (1987). Atrophic cell processes of large motor neurons in the anterior horn in amyotrophic lateral sclerosis: observation with silver impregnation method. J. Neuropathol. Exp. Neurol. 46, 40-49.
34. Naruse, S., Igarashi, S., Kobayashi, H., Aoki, K., Inuzuka, T., Kaneko, K., Shimizu, T., Iihara, K., Kojima, T., Miyatake, T., and Tsuji, S. (1991). Mis-sense mutation Val->Ilein exon 17 of amyloid precursor protein gene in Japanese familial Alzheimer's disease. Lancet 337, 978-979.
35. Perez-Tur, J., Froelich, S., Prihar, G., Crook, R., Baker, M., Duff, K., Wragg, M., Busfield, F., Lendon, C., Clark, R.F., et al. (1995). A mutation in Alzheimer's disease destroying a splice acceptor site in the presenilin-1 gene. Neuroreport 7, 297-301.
36. Rogaev, E.I., Sherrington, R., Rogaeva, E.A., Levesque, G., Ikeda, M., Liang, Y., Chi, H., Lin, C., Holman, K., Tsuda, T., et al. (1995). Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376, 775-778.
37. Schellenberg, G.D. (1995). Genetic dissection of Alzheimer's disease, a heterogeneous disorder. Proc. Natl. Acad. Sci. USA 92, 8552-8559.
38. Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T.D., Hardy, J., Hutton, M., Kukull, W., et al. (1996). Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med. 2, 864-852.
39. Selkoe, D.J. (1997). Alzheimer's disease: genotypes, phenotype, and treatments. Science 275, 630-631.
40. Sherrington, R., Rogaev, E.I., Liang, Y., Rogaeva, E.A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995). Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375, 754-760.
41. Sherrington, R., Froelich, S., Sorbi, S., Campion, D., Chi, H., Rogaeva, E.A., Levesque, G., Rogaev, E.I., Lin, C., Liang, Y., et al. (1996). Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant. Hum. Mol. Genet. 5, 985-988.
42. Shoji, M., Golde, T.E., Ghiso, J., Cheung, T.T., Estus, S., Shatter, L.M., Cai, X.-D., McKay, D.M., Tintner, R., Frangione, B., and Younkin, S.G. (1992). Production of the Alzheimer amyloid β protein by normal proteolytic processing. Science 258, 126-129.
43. Sisodia, S.S., Koo, E.H., Hoffman, P.N., Perry, G., and Price, D.L. (1993). Identification and transport of full-length amyloid precursor proteins in rat peripheral nervous system. J. Neurosci. 13, 3136-3142.
44. St. George-Hyslop, P.H., Haines, P., Rogaev, E., Mortilla, M., Vaula, G., Pericak-Vance, M., Foncin, J.-F., Montesi, M., Bruni, A., Sorbi, S., et al. (1992). Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14. Nature Genet. 2, 330-334.
45. 717) mutants. Science 264, 1336-1340.
46. Terry R., and Katzman, R. (1983). Senile dementia of the Alzheimer type: defining a disease. In The Neurology of Aging, R. Katzman and R. Terry, eds. (Philadelphia: F. A. Davis), pp. 51-84.
47. Thinakaran, G., Borchelt, D.R., Lee, M.K., Slunt, H.H., Spitzer, L., Kim, G., Ratovitski, T., Davenport, F., Nordstedt, C., Seeger, M., et al. (1996). Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron 17, 181-190.
48. Tomita, T., Maruyama, K., Saido, T.C., Kume, H., Shinozaki, K., Tokuhiro, S., Capell, A., Walter, J., Gruenberg, J., Haass, C., et al. (1997). The presenilin 2 mutation (N141I) linked to familial Alzheimer disease (Volga German families) increases the secretion of amyloid β protein ending at the 42nd (or 43rd) residue. Proc. Natl. Acad. Sci. USA 94, 2025-2030.
49. Wasco, W., Pettingell, W.P., Jondro, P.D., Schmidt, S.D., Gurubhagavatula, S., Rodes, L., DiBlasi, T., Romano, D.M., Guenette, S.Y., Kovacs, D.M., et al. (1995). Familial Alzheimer's chromosome 14 mutations. Nature Med. 1, 848.
50. Weidemann, A., König, G., Bunke, D., Fischer, P., Salbaum, J.M., Masters, C.L., and Beyreuther, K. (1989). Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein. Cell 57, 115-126.
51. Wisniewski, T., Ghiso, J., and Frangione, B. (1991). Peptideshomologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation. Biochem. Biophys. Res. Commun. 179, 1247-1254.